Case Western Reserve University's Technology Transfer Office (TTO) serves our innovators with full-spectrum intellectual property services. For both faculty and students, we provide support for intellectual property and commercialization that spans the research & development continuum. We serve our researchers by assessing and building upon the commercial potential of new ideas and inventions.
Through interaction with our inventors, regional and national networks, including our affiliate healthcare systems, and potential commercial partners, we endeavor to determine the best path of translation and ultimate commercialization for University intellectual assets.
Consistent with the University's mission, the Technology Transfer Office is working towards enhancing its role in the promotion of an inclusive culture of global citizenship by exploring issues of access to essential medicines by resource-limited countries. This work includes moving towards the Universities Allied for Essential Medicine's Global Access Licensing Framework.
Breakthrough Device ClotChip Moves Forward Toward Production
--PRNewswire, July 22, 2021
Case Western Reserve University Licenses Rapid Malaria, Hemoglobin Disorder Tests
--AUTM, July 16, 2021
Neuros Medical Receives FDA Breakthrough Device Designation for its Novel Altius® High Frequency Nerve Block System
--Neuros Medical, June 29, 2021
Presidio Medical Announces New Executive Appointment
--BusinessWire, June 28, 2020
Please visit our TTO News webpage for more articles and press releases about TTO success stories.